Automating Critical Drug Discovery Processes with NLP - with Emmanuel Walckenaer of YSEOP

0 Ratings
0
Episode
531 of 962
Duration
28min
Language
English
Format
Category
Economy & Business

Today’s guest is Emmanuel Walckenaer, CEO of YSEOP. A firm based in Paris, YSEOP focuses on natural language generation across financial services and life sciences industries. Emmanuel speaks with us this week about the applications of NLG when it comes to drug discovery and life sciences. Emmanuel also discusses some other life sciences and AI trends that he thinks are promising and some of the trends that he’s seen in his work in the life sciences space. This episode is sponsored by YSEOP. If you’re interested in reaching the Emerj audience, you have an important educational message about use-cases and applications of AI, be sure to contact us at emerj.com/ad1.


Listen and read

Step into an infinite world of stories

  • Read and listen as much as you want
  • Over 1 million titles
  • Exclusive titles + Storytel Originals
  • 14 days free trial, then €9.99/month
  • Easy to cancel anytime
Try for free
Details page - Device banner - 894x1036

Other podcasts you might like ...